Regulation of microsomal triglyceride transfer protein

Clinical Lipidology

Volumn 6, Issue 3, 2011, Pages 293-303

  Hussain, M Mahmood ^a   Nijstad, Niels ^a   Franceschini, Lisa ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

apolipoprotein B; lipid; lipoprotein; microsomal triglyceride transfer protein; regulation; transcription

Indexed keywords

APOLIPOPROTEIN B; BILE ACID; CHENODEOXYCHOLIC ACID; CIS ACTING ELEMENT; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4; INSULIN; LEPTIN; LIPID; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NARINGENIN; PROTEIN IRE1; PROTEIN IRE1BETA; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CIRCADIAN RHYTHM; DRUG BINDING SITE; DRUG PROTEIN BINDING; EMBRYO DEVELOPMENT; ENZYME INHIBITION; GENETIC CONSERVATION; HORMONAL REGULATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INTESTINE CELL; LIPID BLOOD LEVEL; LIPID TRANSPORT; LIPOPROTEIN SECRETION; MACRONUTRIENT; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN SYNTHESIS INHIBITION; REVIEW; TRANSCRIPTION REGULATION;

EID: 79959436320     PISSN: 17460875     EISSN: 17584302     Source Type: Journal    
DOI: 10.2217/clp.11.21     Document Type: Review

References (87)

1. Gordon DA, Jamil H: Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim. Biophys. Acta 1486, 72-83 (2000). (Pubitemid 30336793)
2. Hussain MM, Shi J, Dreizen P: Microsomal triglyceride transfer protein and its role in apolipoprotein B-lipoprotein assembly. J. Lipid Res. 44, 22-32 (2003). (Pubitemid 36114766)
3. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR: The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu. Rev. Nutr. 20, 663-697 (2000).
4. Hussain MM, Bakillah A: New approaches to target microsomal triglyceride transfer protein. Curr. Opin. Lipidol. 19, 572-578 (2008).
5. Paras C, Hussain MM, Rosenson RS: Emerging drugs for hyperlipidemia. Expert. Opin. Emerg. Drugs 15, 433-451 (2010).
6. Madsen EM, Lindegaard ML, Andersen CB, Damm P, Nielsen LB: Human placenta secretes apolipoprotein B-100-containing lipoproteins. J. Biol. Chem. 279, 55271-55276 (2004). (Pubitemid 40066524)
7. Nielsen LB, Veniant M, Boren J et al.: Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins. Circulation 98, 13-16 (1998). (Pubitemid 28312073)
8. Shoulders CC, Brett DJ, Bayliss JD et al.: Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum. Mol. Genet. 2, 2109-2116 (1993). (Pubitemid 24003406)
9. Swift LL, Kakkad B, Boone C et al.: Microsomal triglyceride transfer protein expression in adipocytes: a new component in fat metabolism. FEBS Lett. 579, 3183-3189 (2005). (Pubitemid 40797856)
10. Li CM, Presley JB, Zhang X et al.: Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy. J. Lipid Res. 46, 628-640 (2005). (Pubitemid 43073272)
11. Sharp D, Ricci B, Kienzle B, Lin MCM, Wetterau JR: Human microsomal triglyceride transfer protein large subunit gene structure. Biochemistry 33, 9057-9061 (1994). (Pubitemid 24272853)
12. Narcisi TM, Shoulders CC, Chester SA et al.: Mutations of the microsomal triglyceride-transfer-protein gene in Ab lipoproteinemia. Am. J. Hum. Genet. 57, 1298-1310 (1995).
13. Nakamuta M, Chang BH, Hoogeveen R, Li WH, Chan L: Mouse microsomal triglyceride transfer protein large subunit: cDNA cloning, tissue-specific expression and chromosomal localization. Genomics 33, 313-316 (1996). (Pubitemid 26132131)
14. Dougan SK, Rava P, Hussain MM, Blumberg RS: MTP regulated by an alternate promoter is essential for NKT cell development. J. Exp. Med. 204, 533-545 (2007). (Pubitemid 46457077)
15. Mohler PJ, Zhu MY, Blade AM, Ham AJ, Shelness GS, Swift LL: Identification of a novel isoform of microsomal triglyceride transfer protein. J. Biol. Chem. 282, 26981-26988 (2007). (Pubitemid 47501945)
16. Brozovic S, Nagaishi T, Yoshida M et al.: CD1d function is regulated by microsomal triglyceride transfer protein. Nat. Med. 10, 535-539 (2004). (Pubitemid 38667914)
17. Dougan SK, Salas A, Rava P et al.: Microsomal triglyceride transfer protein: lipidation and control of CD1d on antigen presenting cells. J. Exp. Med. 202, 529-539 (2005). (Pubitemid 41186951)
18. Bartels ED, Nielsen JM, Hellgren LI, Ploug T, Nielsen LB: Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation. PLoS One 4, e5300 (2009).
19. Hagan DL, Kienzle B, Jamil H, Hariharan N: Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes -cell type-specific expression and response to metabolic regulators. J. Biol. Chem. 269, 28737-28744 (1994).
20. Hussain MM, Rava P, Pan X et al.: Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr. Opin. Lipidol. 19, 277-284 (2008). (Pubitemid 351653566)
21. Hirokane H, Nakahara M, Tachibana S, Shimizu M, Sato R: Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4. J. Biol. Chem. 279, 45685-45692 (2004). (Pubitemid 39491557)
22. Dai K, Khatun I, Hussain MM: NR2F1 and IRE1b suppress MTP expression and lipoprotein assembly in undifferentiated intestinal epithelial cells. Arterioscler. Thromb. Vasc. Biol. 30, 568-574 (2010)
23. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ: Hepatocyte nuclear factor 4a (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell Biol. 21, 1393-1403 (2001). (Pubitemid 32114986)
24. Sheena V, Hertz R, Nousbeck J, Berman I, Magenheim J, Bar-Tana J: Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4a. J. Lipid Res. 46, 328-341 (2005). (Pubitemid 40271097)
25. Kang S, Spann NJ, Hui TY, Davis RA: ARP-1/COUP-TF II determines hepatoma phenotype by acting as both a transcriptional repressor of microsomal triglyceride transfer protein and an inducer of CYP7A1. J. Biol. Chem. 278, 30478-30486 (2003). (Pubitemid 36994551)
26. Ameen C, Edvardsson U, Ljungberg A et al.: Activation of peroxisome proliferator-activated receptor a increases the expression and activity of microsomal triglyceride transfer protein in the liver. J. Biol. Chem. 280, 1224-1229 (2005).
27. Wolfrum C, Stoffel M: Coactivation of Foxa2 through Pgc-1b promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab. 3, 99-110 (2006)
28. Kamagate A, Qu S, Perdomo G et al.: FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J. Clin. Invest. 118, 2347-2364 (2008) (Pubitemid 351872351)
29. Sato R, Miyamoto W, Inoue J, Terada T, Imanaka T, Maeda M: Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription. J. Biol. Chem. 274, 24714-24720 (1999).
30. Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL, Shimano H: Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest. 101, 2331-2339 (1998). (Pubitemid 28270427)
31. Horton JD, Shah NA, Warrington JA et al.: Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl Acad. Sci. USA 100, 12027-12032 (2003). (Pubitemid 37271509)
32. Lin J, Yang R, Tarr PT et al.: Hyperlipidemic effects of dietary saturated fats mediated through PGC-1b coactivation of SREBP. Cell 120, 261-273 (2005). (Pubitemid 40174768)
33. Huang J, Iqbal J, Saha PK et al.: Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology 46, 147-157 (2007). (Pubitemid 47171931)
34. Pan X, Zhang Y, Wang L, Hussain MM: Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP. Cell Metab. 12, 174-186 (2010)
35. Lin MCM, Arbeeny C, Bergquist K, Kienzle B, Gordon DA, Wetterau JR: Cloning and regulation of hamster microsomal triglyceride transfer protein -the regulation is independent from that of other hepatic and intestinal proteins which participate in the transport of fatty acids and triglycerides. J. Biol. Chem. 269, 29138-29145 (1994).
36. Qiu W, Taghibiglou C, Avramoglu RK et al.: Oleate-mediated stimulation of microsomal triglyceride transfer protein (MTP) gene promoter: implications for hepatic MTP overexpression in insulin resistance. Biochemistry 44, 3041-3049 (2005). (Pubitemid 40293679)
37. Hernandez Vallejo SJ, Alqub M, Luquet S et al.: Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high-fat diet. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G782-G792 (2009).
38. Iqbal J, Dai K, Seimon T et al.: IRE1b inhibits chylomicron production by selectively degrading MTP mRNA. Cell Metab. 7, 445-455 (2008) (Pubitemid 351598025)
39. Lin MCM, Gordon D, Wetterau JR: Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J. Lipid Res. 36, 1073-1081 (1995).
40. Au WS, Kung HF, Lin MC: Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38. Diabetes 52, 1073-1080 (2003). (Pubitemid 36523339)
41. Allister EM, Borradaile NM, Edwards JY, Huff MW: Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. Diabetes 54, 1676-1683 (2005). (Pubitemid 40770757)
42. Rose BA, Force T, Wang Y: Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 90, 1507-1546 (2010).
43. Mebratu Y, Tesfaigzi Y: How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle 8, 1168-1175 (2009).
44. Taghibiglou C, Carpentier A, Van Iderstine SC et al.: Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J. Biol. Chem. 275, 8416-8425 (2000). (Pubitemid 30180185)
45. Haidari M, Leung N, Mahbub F et al.: Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J. Biol. Chem. 277, 31646-31655 (2002). (Pubitemid 34968968)
46. Carpentier A, Taghibiglou C, Leung N et al.: Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J. Biol. Chem. 277, 28795-28802 (2002).
47. Kuriyama H, Yamashita S, Shimomura I et al.: Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation. Hepatology 27, 557-562 (1998). (Pubitemid 28081073)
48. Bartels ED, Lauritsen M, Nielsen LB: Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes 51, 1233-1239 (2002). (Pubitemid 34438374)
49. Phillips C, Owens D, Collins P, Tomkin GH: Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly? Atherosclerosis 160, 355-360 (2002). (Pubitemid 34159328)
50. Gleeson A, Anderton K, Owens D et al.: The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 42, 944-948 (1999). (Pubitemid 29369602)
51. Phillips C, Bennett A, Anderton K et al.: Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes. Metabolism 51, 847-852 (2002). (Pubitemid 34784809)
52. Sparks JD, Chamberlain JM, O'Dell C, Khatun I, Hussain MM, Sparks CE: Acute suppression of apoB secretion by insulin occurs independently of MTP. Biochem. Biophys. Res. Commun. 406, 252-256 (2011)
53. Iqbal J, Li X, Chang BH et al.: An intrinsic gut leptin-melanocortin pathway modulates intestinal microsomal triglyceride transfer protein and lipid absorption. J. Lipid Res. 51, 1929-1942 (2010).
54. Terasawa Y, Cases SJ, Wong JS et al.: Apolipoprotein B-related gene expression and ultrastructural characteristics of lipoprotein secretion in mouse yolk sac during embryonic development. J. Lipid Res. 40, 1967-1977 (1999). (Pubitemid 29523423)
55. Shelton JM, Lee MH, Richardson JA, Patel SB: Microsomal triglyceride transfer protein expression during mouse development. J. Lipid Res. 41, 532-537 (2000). (Pubitemid 30220656)
56. Raabe M, Flynn LM, Zlot CH et al.: Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc. Natl Acad. Sci. USA 95, 8686-8691 (1998). (Pubitemid 28350549)
57. Farese RV Jr, Ruland SL, Flynn LM, Stokowski RP, Young SG: Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc. Natl Acad. Sci. USA 92, 1774-1778 (1995).
58. Farese RV Jr, Cases S, Ruland SL et al.: A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice. J. Lipid Res. 37, 347-360 (1996). (Pubitemid 26078952)
59. Marza E, Barthe C, Andre M, Villeneuve L, Helou C, Babin PJ: Developmental expression and nutritional regulation of a zebrafish gene homologous to mammalian microsomal triglyceride transfer protein large subunit. Dev. Dyn. 232, 506-518 (2005). (Pubitemid 40129804)
60. Schlegel A, Stainier DY: Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae. Biochemistry 45, 15179-15187 (2006). (Pubitemid 46032444)
61. Xie Y, Newberry EP, Young SG et al.: Compensatory increase in hepatic lipogenesis in mice with conditional intestine-specific Mttp deficiency. J. Biol. Chem. 281, 4075-4086 (2006). (Pubitemid 43847833)
62. Scoville DH, Sato T, He XC, Li L: Current view: intestinal stem cells and signaling. Gastroenterology 134, 849-864 (2008). (Pubitemid 351312767)
63. Hussain MM, Glick JM, Rothblat GH: In vitro model systems: cell cultures used in lipid and lipoprotein research. Curr. Opin. Lipidol. 3, 173-178 (1992).
64. Hussain MM, Kancha RK, Zhou Z, Luchoomun J, Zu H, Bakillah A: Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim. Biophys. Acta 1300, 151-170 (1996). (Pubitemid 26194118)
65. Sun H, Chow EC, Liu S, Du Y, Pang KS: The Caco-2 cell monolayer: usefulness and limitations. Expert. Opin. Drug Metab. Toxicol. 4, 395-411 (2008). (Pubitemid 351728514)
66. Saaf AM, Halbleib JM, Chen X et al.: Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol. Biol. Cell 18, 4245-4260 (2007). (Pubitemid 350060156)
67. Mariadason JM, Nicholas C, L'Italien KE et al.: Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis. Gastroenterology 128, 1081-1088 (2005). (Pubitemid 40523558)
68. Engle MJ, Goetz GS, Alpers DH: Caco-2 cells express a combination of colonocyte and enterocyte phenotypes. J. Cell Physiol. 174, 362-369 (1998). (Pubitemid 28068713)
69. Halbleib JM, Saaf AM, Brown PO, Nelson WJ: Transcriptional modulation of genes encoding structural characteristics of differentiating enterocytes during development of a polarized epithelium in vitro. Mol. Biol. Cell 18, 4261-4278 (2007). (Pubitemid 350060157)
70. Simon-Assmann P, Turck N, Sidhoum-Jenny M, Gradwohl G, Kedinger M: In vitro models of intestinal epithelial cell differentiation. Cell Biol. Toxicol. 23, 241-256 (2007). (Pubitemid 46474917)
71. Hughes TE, Sasak WV, Ordovas JM, Forte TM, Lamon-Fava S, Schaefer EJ: A novel cell line (Caco-2) for the study of intestinal lipoprotein synthesis. J. Biol. Chem. 262, 3762-3767 (1987).
72. Moberly JB, Cole TG, Schonfeld G: Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally. Biochim. Biophys. Acta 1042, 70-80 (1990). (Pubitemid 20021616)
73. Liao W, Chan L: Apolipoprotein B, a paradigm for proteins regulated by intracellular degradation, does not undergo intracellular degradation in CaCo2 cells. J. Biol. Chem. 275, 3950-3956 (2000). (Pubitemid 30094621)
74. Luchoomun J, Hussain MM: Assembly and secretion of chylomicrons by differentiated Caco-2 cells: nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. J. Biol. Chem. 274, 19565-19572 (1999).
75. Hussain MM: A proposed model for the assembly of chylomicrons. Atherosclerosis 148, 1-15 (2000).
76. Hussain MM, Kedees MH, Singh K, Athar H, Jamali NZ: Signposts in the assembly of chylomicrons. Front. Biosci. 6, D320-D331 (2001).
77. Dashti N, Smith EA, Alaupovic P: Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells. J. Lipid Res. 31, 113-123 (1990). (Pubitemid 20038152)
78. Hussain MM, Pan X: Clock genes, intestinal transport and plasma lipid homeostasis. Trends Endocrinol. Metab. 20, 177-185 (2009).
79. Maillot F, Garrigue MA, Pinault M et al.: Changes in plasma triacylglycerol concentrations after sequential lunch and dinner in healthy subjects. Diabetes Metab. 31, 69-77 (2005). (Pubitemid 40327595)
80. Mondola P, Gambardella P, Santangelo F, Santillo M, Greco AM: Circadian rhythms of lipid and apolipoprotein pattern in adult fasted rats. Physiol. Behav. 58, 175-180 (1995).
81. Balasubramaniam S, Szanto A, Roach PD: Circadian rhythm in hepatic low-density-lipoprotein (LDL)-receptor expression and plasma LDL levels. Biochem. J. 298(Pt 1), 39-43 (1994). (Pubitemid 24061539)
82. Bruckdorfer KR, Kang SS, Khan IH, Bourne AR, Yudkin J: Diurnal changes in the concentrations of plasma lipids, sugars, insulin and corticosterone in rats fed diets containing various carbohydrates. Horm. Metab. Res. 6, 99-106 (1974).
83. Pan X, Hussain MM: Diurnal regulation of microsomal triglyceride transfer protein and plasma lipid levels. J. Biol. Chem. 282, 24707-24719 (2007).
84. Pan X, Hussain MM: Clock is important for food and circadian regulation of macronutrient absorption in mice. J. Lipid Res. 50, 1800-1813 (2009).
85. Bertolotti A, Wang X, Novoa I et al.: Increased sensitivity to dextran sodium sulfate colitis in IRE1b-deficient mice. J. Clin. Invest. 107, 585-593 (2001). (Pubitemid 32205179)
86. Qiu W, Federico L, Naples M et al.: Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins. Hepatology 48, 1799-1809 (2008).
87. Pan X, Hussain FN, Iqbal J, Feuerman MH, Hussain MM: Inhibiting proteasomal degradation of microsomal triglyceride transfer protein prevents CCl4 induced steatosis. J. Biol. Chem. 282, 17078-17089 (2007). (Pubitemid 47093224)